Aratana Therapeutics Acquires Okapi Sciences NV

News   Jan 07, 2014

 
Aratana Therapeutics Acquires Okapi Sciences NV
 
 
 
 

RELATED ARTICLES

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

NIH links Aldosterone to Alcohol Use Disorder

News

National Institutes of Health study demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute to alcohol use disorder (AUD)

READ MORE

Bone Cancer Drug Targets Tumors, Spares Other Organs

News

A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE